InvestorsHub Logo

biotech2

12/17/17 9:20 AM

#12895 RE: Biotech Pharmer #12894

my guess is a 10 for 1 RS in 2018, worst case 15 for 1. Either one would be great because gettting uplisted to NASDAQ will greatly enhance valuation because so many institutions just dont buy down here in penny stock pink sheet land. Need to reduce number of shares to decrease float. Holding long and strong for 2018 !!!!!!!!!!!!!!